HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

anti-CD19 CAR-T cells

SUSPENDED · PHASE1 · Systemic Sclerosis (SSc)

temporarily suspended due to no new subjects at present

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.